Countagen’s patent-pending technology is being used to develop GeneAbacus™ solutions – gene editing analysis tools designed to accelerate genomic research, enabling researchers to move swiftly and confidently from gene edit to clone selection for functional analysis or to decide upon their editing strategy.
Gene editing has opened many opportunities to transform research, drug development and personalized medicine, enabling scientists to choose where to edit a gene in order to disable or activate a gene or to insert a completely new gene at a specific location. However, gene editing techniques are not perfect. To increase the chance of a successful project and avoid wasting time and resources, it is essential to determine the efficiency and specificity of an editing experiment before moving forward.
The people supporting product development at Countagen have decades of experience and knowledge in quantification and identification of nucleic acids, development of rapid, highly precise assays and delivery of user-friendly consumable solutions.